Middle East respiratory syndrome coronavirus infection epidemiology and demographics: Difference between revisions
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) |
||
Line 21: | Line 21: | ||
===Developed Countries=== | ===Developed Countries=== | ||
Only travel-associated MERS-CoV infection has also been reported in developed countries. | Only travel-associated MERS-CoV infection has also been reported in developed countries. At least one MERS-CoV case has been reported in the following countries: | ||
*United States of America (USA) | *United States of America (USA) | ||
*United Kingdom (UK) | *United Kingdom (UK) |
Revision as of 15:21, 15 June 2015
Middle East Respiratory Syndrome Coronavirus Infection Microchapters |
Differentiating Middle East Respiratory Syndrome Coronavirus Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Middle East respiratory syndrome coronavirus infection epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Middle East respiratory syndrome coronavirus infection epidemiology and demographics |
FDA on Middle East respiratory syndrome coronavirus infection epidemiology and demographics |
CDC on Middle East respiratory syndrome coronavirus infection epidemiology and demographics |
Middle East respiratory syndrome coronavirus infection epidemiology and demographics in the news |
Blogs on Middle East respiratory syndrome coronavirus infection epidemiology and demographics |
Directions to Hospitals Treating Middle East respiratory syndrome coronavirus infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2], Alejandro Lemor, M.D. [3]
Overview
All reported cases have been linked to countries in and near the Arabian Peninsula. Most infected people either lived in the Arabian Peninsula or recently traveled from the Arabian Peninsula before they became ill. A few people became infected with MERS-CoV after having close contact with an infected person who had recently traveled from the Arabian Peninsula.
Epidemiology and Demographics
Incidence
- As of February 2015, 971 laboratory-confirmed cases of MERS-CoV infection have been reported.
Case Fatality Rate
- As of January 2015, 356 MERS-CoV-related deaths have been reported. The case fatality rate of MERS-CoV ranges between 35% to 40%.
Age
- There is no age preponderance to MERS-CoV infection (range: 9 months to 94 years).
- Among infected patients, the median age is 47 years.
Gender
- There is a male preponderance to MERS-CoV infection. The male-to-female ratio is 1.6 to 1.0.
Developed Countries
Only travel-associated MERS-CoV infection has also been reported in developed countries. At least one MERS-CoV case has been reported in the following countries:
- United States of America (USA)
- United Kingdom (UK)
- France
- Germany
- Italy
- Netherlands
- Austria
- Republic of Korea
Developing Countries
MERS-CoV has been associated with residence in or recent travel to the following countries:
- Saudi Arabia
- United Arab Emirates (UAE)
- Qatar
- Jordan
- Oman
- Kuwait
- Yemen
- Lebanon
- Iran
Other countries with travel-associated MERS-CoV infection:
- China
- Algeria
- Egypt
- Malaysia
- Philippines
- Tunisia
- Turkey
- Greece